Search


EMA & HC Guidance: Clinical Data Publication (CDP) – EMA Policy 0070 Work-Share with Health Canada
The European Medicines Agency (EMA) continues to strengthen transparency, data sharing, and international regulatory collaboration through its Clinical Data Publication (CDP) framework. A key development in this area is the introduction of a work-share initiative with Health Canada (HC) under Policy 0070, aimed at improving efficiency while maintaining robust safeguards for sensitive information. The guidance Clinical Data Publication (CDP): Questions and Answers on EMA Polic

Sharan Murugan
3 days ago3 min read


EMA Policy 0070 Guidance: Transparency in Clinical Data Publication – Version 1.5 (May 2025)
The European Medicines Agency (EMA) has long committed to this principle through Policy 0070, which governs the publication of clinical...

Sharan Murugan
May 17, 20253 min read


EMA Interim Guidance: How to Approach the "PPD and CCI" while using CTIS
Last Week (03 May 2023) the European Medicines Agency released an Interim guidance document on "How to Approach the Protection of...

Sharan Murugan
May 7, 20232 min read


EMA Guidance: Anonymisation of PPD & CCI - Preparation of Risk Management Plans (RMP)
Today (04-November-2022) European Medicines Agency, released updated guidance on "Anonymisation of Protected Personal Data and assessment...

Sharan Murugan
Nov 4, 20221 min read
